Shire insists AbbVie’s offer 'undervalues' company as shares slide
The ADHD drugmaker has already rejected three bids from Abbvie
Shares in Shire fell almost 2 per cent in early London trading as the pharmaceutical giant stepped up its defence against a £27 billion takeover from United States rival AbbVie.
The ADHD drugmaker, which shifted its headquarters to Dublin in 2008 to take advantage of Ireland’s low corporate tax rate, has already rejected three bids from Abbvie, the last one valuing it at £46.26 a share.
But in a call to investors and City analysts this afternoon, Shire followed AstraZeneca’s lead by giving long-range sales forecasts for its drugs in a bid to convince shareholders that AbbVie’s offer undervalues the business.
Shire’s chairman Susan Kilsby and chief executive Flemming Ornskov are claiming the drugmaker will more than double annual revenues to $10 billion (£5.9 billion) by 2020 as an independent business.
This would be helped by Vyvanse, the ADHD treatment which brought in almost 25 per cent of Shire’s $4.8 billion revenues last year and is being tested to help patients addicted to binge-eating.
The executives also highlighted the risks associated with AbbVie’s plan to cut its corporate tax bill by redomiciling in Britain. The ambition has sparked growing political concerns.
Pharma analysts at Jefferies predict Shire investors would back a deal priced at about £55 a share. Shares in Shire, which hit an all-time high on Friday, fell 60p to 4311p.
- 1 2015 General Election: Green party will not appear in TV debate alongside Ukip – says BBC
- 2 Canadian actor punched in face after 'Islamophobia' experiment goes wrong in wake of Ottawa shooting
- 3 Topshop at centre of row over body image as 'shocking' skinny mannequin photo goes viral
- 4 Kentucky gang rape: 15-year-old boy left in critical condition after sexual attack by group at party
- 5 Of course, teenage girls need role models – but not like beauty vlogger Zoella
'Nasa Confirms Six Days of Darkness in December': No, they don't - it's a hoax
Canadian actor punched in face after 'Islamophobia' experiment goes wrong in wake of Ottawa shooting
Tim Cook: Apple CEO comes out as gay publicly for the first time 'It's among the greatest gifts God has given me'
Topshop at centre of row over body image as 'shocking' skinny mannequin photo goes viral
Halloween 2014: From the Screaming Man of Pluckley to the 'White Lady' of the Tower of London - Britain's 20 most haunted places
Pope Francis declares evolution and Big Bang theory are real and God is not 'a magician with a magic wand'
Huge surge in Ukip support after EU funding row, according to new poll
Ukip ‘exploiting grooming scandal’ to secure party’s first police chief
Nigel Farage: 'There’s nothing wrong with white people blacking up'
Muslims, immigration and teenage pregnancy: British people are ignorant about almost everything
Maureen Lipman says 'she can't vote Labour while Ed Miliband is leader'
iJobs Money & Business
£20000 - £23250 Per Annum pro rata: Clearwater People Solutions Ltd: Pro rata ...
£40 - 48k + Benefits: Guru Careers: We are seeking a Marketing Manager to join...
£45,000 - £65,000: Saxton Leigh: Our client is a well-known APAC Corporate and...
£60000 per annum: Ashdown Group: Compensation and Benefits Manager - Compensat...